Question

Difficulty: MediumEndocrinology and Metabolism

A 3232-year-old woman comes to the clinic for a routine wellness evaluation. Over the past three months, she noticed increased hair shedding and brittle nails, prompting her to start taking a daily over-the-counter multi-ingredient cosmetic supplement. She reports no palpitations, heat intolerance, weight changes, anxiety, or changes in bowel habits. Her medical history is unremarkable, and she takes no prescription medications.

Vitals:
Temperature: 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F})
Blood pressure: 118/76 mm Hg118/76\text{ mm Hg}
Pulse: 74/min74/\text{min}
Respirations: 14/min14/\text{min}

Physical examination shows a normal-sized, non-tender thyroid gland with no palpable nodules. There is no tremor, and deep tendon reflexes are normal (2+2+) and symmetric. Eye examination shows no proptosis, lid retraction, or periorbital edema.

Laboratory results:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)<0.01 \muU/mL<0.01\text{ \mu U/mL}0.5−5.0 \muU/mL0.5-5.0\text{ \mu U/mL}
Free thyroxine (T4)2.8 ng/dL2.8\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}
Free triiodothyronine (T3)5.2 pg/mL5.2\text{ pg/mL}2.0−4.4 pg/mL2.0-4.4\text{ pg/mL}

Which of the following is the most appropriate next step in the management of this patient?

  1. Discontinue the current supplements and repeat thyroid function testsAnswer
  2. B
    Prescribe methimazole therapy
  3. C
    Order a radioactive iodine uptake scan
  4. D
    Measure serum thyrotropin receptor antibodies
  5. E
    Measure serum thyroglobulin concentration

Answer

The most appropriate next step is to discontinue the current cosmetic supplements and repeat the thyroid function tests after a few days.
This patient's laboratory profile (suppressed TSH, elevated free T4 and free T3) suggests overt primary hyperthyroidism. However, her clinical presentation is entirely normal (euthyroid), with a normal heart rate, normal reflexes, and no symptoms of thyrotoxicosis. This striking incongruence points to a laboratory artifact. She recently started taking over-the-counter cosmetic supplements for hair and nails, which typically contain high doses of biotin (vitamin B7). Many modern hospital laboratories utilize streptavidin-biotin binding to anchor antibodies in their immunoassays. High concentrations of exogenous serum biotin competitively interfere with this assay. In competitive assays (used to measure small molecules like free T4 and T3), this leads to a falsely elevated result. In sandwich assays (used to measure larger molecules like TSH), biotin interference prevents the sandwich from binding to the solid phase, leading to a falsely suppressed result. The appropriate next step is to instruct the patient to discontinue the supplement and re-draw the labs in 2 to 3 days to allow the water-soluble biotin to clear.

Step-by-Step Solution

1
Evaluate the clinical presentation and physical exam.
The patient is completely asymptomatic (normal heart rate, no tremor, normal reflexes) and has a normal physical examination.
Establishing the clinical baseline is necessary to contextualize laboratory data.
2
Interpret the laboratory findings.
Labs show a suppressed TSH with markedly elevated free T4 and free T3, which typically indicates severe primary hyperthyroidism.
Recognizing the pattern of primary hyperthyroidism allows for comparison against the clinical picture.
3
Identify the discrepancy between clinical and laboratory data.
There is a massive mismatch between the severe biochemical thyrotoxicosis and the completely asymptomatic euthyroid state of the patient.
A severe discrepancy suggests either a laboratory artifact or an extreme form of hormone resistance.
4
Incorporate the patient's history.
The patient recently started over-the-counter hair and nail supplements, which frequently contain large doses of biotin (Vitamin B7).
Biotin interferes with the streptavidin-biotin binding mechanisms used in common thyroid immunoassays, causing falsely high T4/T3 and falsely low TSH.
5
Determine the management plan.
The biotin-containing supplement must be stopped, and the laboratory tests should be repeated in 2 to 3 days.
Removing the interfering agent will yield accurate thyroid function tests and confirm the patient's euthyroid state.

Key Concept

Biotin interference with streptavidin-biotin immunoassays creates a false biochemical profile of primary hyperthyroidism (falsely elevated T4/T3, falsely suppressed TSH) in clinically euthyroid patients.
Rate this question